These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32963318)

  • 1. Comparison of ultrasmall IONPs and Fe salts biocompatibility and activity in multi-cellular in vitro models.
    Janik-Olchawa N; Drozdz A; Ryszawy D; Pudełek M; Planeta K; Setkowicz Z; Śniegocki M; Żądło A; Ostachowicz B; Chwiej J
    Sci Rep; 2020 Sep; 10(1):15447. PubMed ID: 32963318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of IONPs core size on their biocompatibility and activity in in vitro cellular models.
    Janik-Olchawa N; Drozdz A; Ryszawy D; Pudelek M; Planeta K; Setkowicz Z; Sniegocki M; Wytrwal-Sarna M; Gajewska M; Chwiej J
    Sci Rep; 2021 Nov; 11(1):21808. PubMed ID: 34750434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical changes of macrophages and U87MG cells occurring as a result of the exposure to iron oxide nanoparticles detected with the Raman microspectroscopy.
    Janik-Olchawa N; Drozdz A; Wajda A; Sitarz M; Planeta K; Setkowicz Z; Ryszawy D; Kmita A; Chwiej J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 278():121337. PubMed ID: 35537264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.
    Sun Z; Yathindranath V; Worden M; Thliveris JA; Chu S; Parkinson FE; Hegmann T; Miller DW
    Int J Nanomedicine; 2013; 8():961-70. PubMed ID: 23494517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choose your cell model wisely: The in vitro nanoneurotoxicity of differentially coated iron oxide nanoparticles for neural cell labeling.
    Joris F; Valdepérez D; Pelaz B; Wang T; Doak SH; Manshian BB; Soenen SJ; Parak WJ; De Smedt SC; Raemdonck K
    Acta Biomater; 2017 Jun; 55():204-213. PubMed ID: 28373085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.
    Dan M; Scott DF; Hardy PA; Wydra RJ; Hilt JZ; Yokel RA; Bae Y
    Pharm Res; 2013 Feb; 30(2):552-61. PubMed ID: 23080062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells.
    Wu X; Tan Y; Mao H; Zhang M
    Int J Nanomedicine; 2010 Aug; 5():385-99. PubMed ID: 20957160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of T2* Weighted MRI Imaging Sensitivity of U87MG Glioblastoma Cells Using γ-Ray Irradiated Low Molecular Weight Hyaluronic Acid-Conjugated Iron Nanoparticles.
    Huang HM; Wu PH; Chou PC; Hsiao WT; Wang HT; Chiang HP; Lee CM; Wang SH; Hsiao YC
    Int J Nanomedicine; 2021; 16():3789-3802. PubMed ID: 34103915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and interfacing of biocompatible iron oxide nanoparticles through the ferroxidase activity of Helicobacter Pylori ferritin.
    Lee IL; Li PS; Yu WL; Shen HH
    Biofabrication; 2012 Dec; 4(4):045001. PubMed ID: 23013844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papain grafted into the silica coated iron-based magnetic nanoparticles 'IONPs@SiO
    Nasiri R; Dabagh S; Meamar R; Idris A; Muhammad I; Irfan M; Rashidi Nodeh H
    Nanotechnology; 2020 May; 31(19):195603. PubMed ID: 31978907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
    Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
    Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes.
    Petters C; Thiel K; Dringen R
    Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro.
    Sharma G; Kodali V; Gaffrey M; Wang W; Minard KR; Karin NJ; Teeguarden JG; Thrall BD
    Nanotoxicology; 2014 Sep; 8(6):663-75. PubMed ID: 23837572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor.
    Nosrati H; Salehiabar M; Fridoni M; Abdollahifar MA; Kheiri Manjili H; Davaran S; Danafar H
    Sci Rep; 2019 May; 9(1):7173. PubMed ID: 31073222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term live cells observation of internalized fluorescent Fe@C nanoparticles in constant magnetic field.
    Garanina A; Kireev I; Zhironkina O; Strelkova O; Shakhov A; Alieva I; Davydov V; Murugesan S; Khabashesku V; Majouga A; Agafonov V; Uzbekov R
    J Nanobiotechnology; 2019 Feb; 17(1):27. PubMed ID: 30728022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tolerability of dextran-coated iron oxide nanoparticles during in vivo observation of the rats.
    Popa CL; Prodan AM; Ciobanu CS; Predoi D
    Gen Physiol Biophys; 2016 Jul; 35(3):299-310. PubMed ID: 27045672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of magnetic albumin nanoparticles via a simple and one-pot desolvation and co-precipitation method for medical and pharmaceutical applications.
    Nosrati H; Salehiabar M; Manjili HK; Danafar H; Davaran S
    Int J Biol Macromol; 2018 Mar; 108():909-915. PubMed ID: 29101048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
    Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
    Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.